# Averitas Pharma, Inc.

Canonical: https://abierto.us/vendors/averitas-pharma-inc-qu48mtf1kbt5

- UEI: QU48MTF1KBT5
- CAGE: 85WE5
- Parent: Grunenthal Pharma GMBH & Co
- Location: Morristown, NJ
- Awards in window: 3 (14 transactions), $0 obligated, March 14, 2024 to June 2, 2026

## Awarding agencies

- Department of Veterans Affairs: 3 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 3 awards

## Solicitations won

- Averitas Pharma, Inc., 65IB, 36F79725D0245 Performance Period: 09/29/2025 - 09/28/2030 (36F79725D0245), $19,239,160. https://abierto.us/opportunities/36f79725d0245

## Largest awards

- 36E79719A0017: $0, Nac Pharmaceuticals. BPA Cancellation - Product Is Available for Purchase Via the PPV. https://www.usaspending.gov/award/CONT_IDV_36E79719A0017_3600/
- 36F79719D0131: $0, Nac Federal Supply Schedule. Temporary Contract Extension. https://www.usaspending.gov/award/CONT_IDV_36F79719D0131_3600/
- 36F79725D0245: $0, Nac Federal Supply Schedule. 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award. https://www.usaspending.gov/award/CONT_IDV_36F79725D0245_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/averitas-pharma-inc-qu48mtf1kbt5.